戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 , such as in the use of CT or PET to predict radiation pneumonitis.
2                       There were no cases of radiation pneumonitis.
3 s were chosen based on the estimated risk of radiation pneumonitis.
4  histopathological change that occurs during radiation pneumonitis.
5 ly, there are no biomarkers that can predict radiation pneumonitis.
6  patient included transient hypoxemia (19%), radiation pneumonitis (11%), and fatigue (4%).
7  the once-daily group; p=0.85) and grade 3-4 radiation pneumonitis (4 [3%] of 254 vs 4 [2%] of 246; p
8 the lung dose and the eventual occurrence of radiation pneumonitis after (90)Y radioembolization was
9 7.7 Gy and an LMD(MAA) of 34.1 Gy) developed radiation pneumonitis and consequently died.
10       We have also developed a mitigator for radiation pneumonitis and fibrosis that can be started a
11 rasting findings regarding the occurrence of radiation pneumonitis and lung dose were previously repo
12 ic infections, diffuse pulmonary malignancy, radiation pneumonitis, and oxygen toxicity.
13  and gastrointestinal ulcers, cholecystitis, radiation pneumonitis, and radioembolization-induced liv
14                Conclusion: The occurrence of radiation pneumonitis as a consequence of a lung shunt a
15 ntestinal reflux disease, pain exacerbation, radiation pneumonitis, brachial plexopathy, and low bloo
16 importance of visual assessment to recognize radiation pneumonitis, changes in lung configuration, an
17                                           No radiation pneumonitis developed in patients with a measu
18  initially thought to have died from grade 5 radiation pneumonitis during the study; however, this ad
19 ized two well-characterized murine models of radiation pneumonitis/fibrosis to compare and contrast d
20                          Early prediction of radiation pneumonitis in time to initiate mitigation wil
21                                              Radiation pneumonitis is a rare but possibly fatal side
22                                              Radiation pneumonitis is reported in 5% to 15% of lung c
23 mertinib group and 12% in the placebo group; radiation pneumonitis (majority grade, 1 to 2) was repor
24                             Although grade 2 radiation pneumonitis occurred in five patients, grade 3
25 eumonitis occurred in five patients, grade 3 radiation pneumonitis occurred in only two.
26 point was the incidence of grade 3 or higher radiation pneumonitis (RP) or any grade 4 toxicity withi
27                                              Radiation pneumonitis (RP) that develops early (i.e., wi
28 oint was the incidence of grade 3 or greater radiation pneumonitis (RP).
29  and/or radiographic changes consistent with radiation pneumonitis (t1/2 felt to 19% +/- 6% of baseli
30                               Pneumonitis or radiation pneumonitis with a maximum grade of 3 or 4 occ
31 d according to patients' stratified risk for radiation pneumonitis with total RT doses ranging from 5